Richard Mason, Apollo Therapeutics CEO
A UK biotech looks to bring alliance between GSK, J&J, AstraZeneca, and top universities stateside with its first megaround
Richard Mason was working at the J&J Innovation Center in London about six years ago when the company linked arms with two other pharmas and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
